<unk>  under the brand name Temtabs 10 mg tablets in Australia. In sleep laboratory studies,<unk>  significantly decreased the number of nightly awakenings, but has the drawback of distorting the normal sleep pattern. It is officially indicated for severe insomnia and other severe or disabling sleep disorders. The prescribing guidelines in the UK limit the prescribing of hypnotics to two to four weeks due to concerns of tolerance and dependence. The American Academy of Sleep Medicine's 2017 clinical practice guidelines recommended the use of<unk>  in the treatment of sleep-onset and sleep-maintenance insomnia. It rated the recommendation as weak, the quality of evidence as moderate, and concluded that the potential benefits outweighed the potential harms. The guidelines found that<unk>  at a dose of 15mg reduces sleep latency by 37minutes (95% 21 to 53minutes), increases total sleep time by 99minutes (95% 63 to 135minutes), and provides a small improvement to sleep quality. The improvements in sleep latency and total sleep time were numerically much greater than any of the other included sleep medications. The United States Air Force uses<unk>  as one of the hypnotics approved as a "no-go pill" to help aviators and special-duty personnel sleep in support of mission readiness. "Ground tests" are necessary prior to required authorization being issued to use the medication in an operational situation, and a 12-hour restriction is imposed on subsequent flight operation. The other hypnotics used as "no-go pills" are zaleplon and zolpidem, which have shorter mandatory recovery periods. Available forms<unk>  is available in the form of 7.5, 15, 22.5, and 30mg oral capsules.
Temazepam
Oxazepam
Medazepam
Diclazepam
Halazepam
Camazepam
Cinolazepam
Quazepam